About
Addex Therapeutics Ltd — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 30 2026
Addex Reports Full Year 2025 Financial Results and Provides Corporate Update
Apr 29 2026
Addex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
Apr 23 2026
Addex Spin-Out Company Neurosterix on Track to Complete Phase 1 Clinical Study of NTX-253 for Schizophrenia in Q2 2026
Apr 21 2026
Addex GABAB PAM Candidate Demonstrates Robust Anti-Tussive Activity in Non-Human Primate Chronic Cough Model
Feb 3 2026
Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Treatment
Recent Videos

Addex Therapeutics Targets IPF Cough | US FDA Halts Newron Pharmaceuticals Trial
May 04, 2026

Addex Therapeutics Ltd Q3 2025 Earnings Call 2025
Dec 06, 2025

Addex Therapeutics (ADXN|$8.6M) - 2025 Q3 Earnings Analysis
Dec 05, 2025

#Addex Pvt Ltd company Miyapur office #instagram #healthproduct #hyderabad
Nov 29, 2025
Translate